Changzhou No.2 People's Hospital
Changzhou No.2 People's Hospital
Changzhou, China3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Active, not recruiting | Phase 3 | 2026-04-20 | NCT03519945 | |
| UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases | Hemic and Lymphatic Diseases, Immunoglobulin G4-Related Disease, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Skin and Connective Tissue Diseases, anemia, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune hemolytic anemia, cardiovascular disorder, connective tissue disorder, hematologic disorder, hemolytic anemia, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myasthenia gravis, myositis disease, necrotizing vasculitis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis | Not yet recruiting | Phase 1 | 2025-05-18 | NCT06978738 | |
| FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 2 | 2025-02-20 | NCT06405113 |